-
Register now for Duke OHRP conference; AAHRPP accredits its first international site
-
-
-
In conjunction with the Japan Heart Rhythm Society annual meeting in Tokyo in early July, Medtronic (Minneapolis) reported Ministry of Health, Labor and Welfare (MHLW) approval of the Medtronic InSync III Marquis cardiac resynchronization therapy-defibrillator (CRT-D) in Japan.
-
Boston Scientific (Natick, Massachusetts) earlier this year completed the purchase of Guidant (Indianapolis). And while it has renamed the company as its Cardiac Rhythm Management (CRM) unit as a way of...
-
Bioheart (Sunrise, Florida), focused on developing, testing and commercializing cell-based therapies for the treatment of cardiovascular diseases, said that it will receive funds from a grant awarded by the Biomedical Research and Commercialization Program of the state of Ohio.
-
Researchers at the McEwen Centre for Regenerative Medicine at Toronto General Hospital have reported discovering what is called the "SOS" distress signal that mobilizes specific heart repair cells from the bone marrow to the injured heart after a heart attack.
-
William Young has been appointed vice president of quality assurance and reliability for the Cardiac Rhythm Management group of Boston Scientific (Natick, Massachusetts). He will be based at the company's St. Paul, Minnesota, facility.
-
On the one hand is the "winged chariot" of time, a vehicle that the FDA can slow rather substantially - and often does.
-
The rather obvious differences between men and women are, well . . . rather obvious. And they should be most obvious to those in healthcare.
